NEW YORK (GenomeWeb News) – The DNA Medicine Institute has won a Small Business Innovation Research contract worth $600,000 over two years from the National Aeronautics and Space Administration to develop nanoscale diagnostic assays for analyzing health from blood samples.

The for-profit firm, which bases its products on nanotechnology, genomics, and molecular biology among others, will use the Phase II funding to develop assays for assessment of bone loss, immune function, cardiac health, liver function, and lipid status.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.